Search Results - "Ruiz, M Victoria Mier"
-
1
Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms
Published in Scientific reports (12-09-2018)“…In chronic kidney disease (CKD), high serum phosphate concentration is associated with cardiovascular disease and deterioration in renal function. In early…”
Get full text
Journal Article -
2
FGF23, Biomarker or Target?
Published in Toxins (22-03-2019)“…Fibroblast growth factor 23 (FGF23) plays a key role in the complex network between the bones and other organs. Initially, it was thought that FGF23…”
Get full text
Journal Article -
3
Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients
Published in BMC nephrology (15-06-2020)“…Background Acute kidney injury (AKI) occurs in 12-20% of multiple myeloma (MM) patients. Several studies have shown a reduction of free light chains (FLC)…”
Get full text
Journal Article -
4
Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure
Published in Antioxidants (27-01-2023)“…Metabolic syndrome (MetS) and chronic kidney disease (CKD) are commonly associated with cardiovascular disease (CVD) and in these patients Mg concentration is…”
Get full text
Journal Article -
5
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
Published in Clinical kidney journal (01-03-2021)“…In dialysis patients, non-adherence to oral cinacalcet adds complexity to the control of secondary hyperparathyroidism. The present study aims to evaluate the…”
Get full text
Journal Article -
6
Phosphate control in reducing FGF23 levels in hemodialysis patients
Published in PloS one (07-08-2018)“…In hemodialysis patients, high levels of Fibroblast Growth Factor 23 (FGF23) predict mortality. Our study was designed to test whether the control of serum…”
Get full text
Journal Article -
7
The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities
Published in Frontiers in cell and developmental biology (12-11-2020)“…Some of the critical mechanisms that mediate chronic kidney disease (CKD) progression are associated with vascular calcifications, disbalance of mineral…”
Get full text
Journal Article -
8
Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats
Published in Kidney international (01-11-2017)“…Although magnesium has been shown to prevent vascular calcification in vitro, controlled in vivo studies in uremic animal models are limited. To determine…”
Get more information
Journal Article -
9
The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function
Published in Nephrology, dialysis, transplantation (13-02-2023)“…In chronic kidney disease (CKD) patients, increased levels of fibroblast growth factor 23 (FGF23) are associated with cardiovascular mortality. The…”
Get full text
Journal Article -
10
Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration
Published in Kidney international (01-05-2019)“…Calcimimetics decrease parathyroid hormone (PTH) secretion in patients with secondary hyperparathyroidism. The decrease in PTH should cause a reduction in bone…”
Get more information
Journal Article -
11
Trimethylamine N-Oxide and Coronary Heart Disease: Should We Consider the Kidney Function?
Published in Journal of the American College of Cardiology (23-06-2020)Get full text
Journal Article -
12
Prospective study of the complications associated with percutaneous renal biopsy of native kidneys: experience in a centre
Published in Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (21-05-2014)“…Percutaneous renal biopsy (PRB) is a key invasive technique in the study of kidney disease and it is associated with considerable morbidity. Retrospective…”
Get more information
Journal Article -
13
1514 Elevated FGF23 increases systolic, and diastolic blood pressure, and pulse pressure in non-dialysis CKD patients
Published in Nephrology, dialysis, transplantation (23-05-2024)Get full text
Journal Article -
14
1610 FGF23-mediated hypertension via augmented calcium entry in vascular smooth muscle cells
Published in Nephrology, dialysis, transplantation (23-05-2024)Get full text
Journal Article -
15
Trimethylamine N-Oxide and Coronary Heart Disease
Published in Journal of the American College of Cardiology (23-06-2020)Get full text
Journal Article -
16
-
17
MO022URINARY PHOSPHATE/UREA RATIO, A NEW TOOL TO EVALUATE ADHERENCE TO PHOSPHATE DIETARY INTERVENTIONS IN CKD PATIENTS
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims In chronic kidney disease (CKD) patients, phosphate (P) restriction is crucial for the control of mineral metabolism. Many reports…”
Get full text
Journal Article -
18
P0888FIBROBLAST GROWTH FACTOR 23 PRODUCES ARTERIAL STIFFNESS THROUGH CHANGES IN VASCULAR SMOOTH MUSCLE CELL PHENOTYPE
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims In patients with chronic kidney disease (CKD), high levels of c-terminal fibroblast growth factor 23 (FGF23) are associated with…”
Get full text
Journal Article -
19
Variability in the structure and operation of out-of-hospital emergency services in Spain. Spanish Registry of out-of-hospital cardiac arrest
Published in Resuscitation (01-05-2014)Get full text
Journal Article -
20
1496 High levels of sclerostin promote bone resorption and changes and mineral metabolism
Published in Nephrology, dialysis, transplantation (23-05-2024)Get full text
Journal Article